Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
572.77
-2.47 (-0.43%)
At close: Dec 5, 2025, 4:00 PM EST
572.81
+0.04 (0.01%)
After-hours: Dec 5, 2025, 7:05 PM EST
Revenue Breakdown
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 27, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Life Sciences Solutions Revenue | 10.03B | 9.63B |
Log In |
Log In |
Log In | Upgrade
|
| Analytical Instruments Revenue | 7.53B | 7.46B |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Diagnostics Revenue | 4.61B | 4.51B |
Log In |
Log In |
Log In | Upgrade
|
| Laboratory Products and Biopharma Services Revenue | 23.54B | 23.16B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | -1.98B | -1.88B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 43.74B | 42.88B |
Log In |
Log In |
Log In | Upgrade
|
Revenue Breakdown 2
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 27, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Consumables Revenue | 18.16B | 17.59B |
Log In |
Log In |
Log In | Upgrade
|
| Instruments Revenue | 7.33B | 7.45B |
Log In |
Log In |
Log In | Upgrade
|
| Services Revenue | 18.25B | 17.85B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 43.74B | 42.88B |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 27, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| North America Revenue | 22.79B | 22.50B |
Log In |
Log In |
Log In | Upgrade
|
| Europe Revenue | 11.35B | 10.86B |
Log In |
Log In |
Log In | Upgrade
|
| Asia-Pacific Revenue | 8.03B | 7.96B |
Log In |
Log In |
Log In | Upgrade
|
| Other Regions Revenue | 1.57B | 1.56B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | - | 1.00M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 43.74B | 42.88B |
Log In |
Log In |
Log In | Upgrade
|
EBIT
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 27, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2013 - 2020 |
| Life Sciences Solutions Operating Income | 3.67B | 3.50B |
Log In |
Log In |
Log In | Upgrade
|
| Analytical Instruments Operating Income | 1.82B | 1.96B |
Log In |
Log In |
Log In | Upgrade
|
| Specialty Diagnostics Operating Income | 1.20B | 1.16B |
Log In |
Log In |
Log In | Upgrade
|
| Laboratory Products and Biopharma Services Operating Income | 3.25B | 3.09B |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Other) | -2.44B | -2.37B |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | 7.51B | 7.34B |
Log In |
Log In |
Log In | Upgrade
|
Key Performance Indicators
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2019 |
| Total Organic Revenue Growth | - |
Log In |
Log In |
Log In | Upgrade
|
| Core Organic Revenue Growth | - |
Log In |
Log In |
Log In | Upgrade
|